Michael P Manns Selected Research

Immunoglobulin G (IgG)

4/2022	Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.
1/2022	Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.
12/2018	Autoimmune hepatitis.
1/2015	Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis.
10/2013	Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
1/2010	Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
1/2006	Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael P Manns Research Topics

Disease

137	Infections 02/2022 - 01/2002
87	Neoplasms (Cancer) 01/2021 - 02/2002
69	Fibrosis (Cirrhosis) 01/2022 - 02/2002
67	Liver Diseases (Liver Disease) 01/2022 - 02/2002
59	Chronic Hepatitis C 02/2022 - 02/2002
51	Hepatitis C 01/2022 - 01/2002
50	Autoimmune Hepatitis 04/2022 - 01/2002
50	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2002
45	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 02/2002
29	Hepatitis 01/2021 - 02/2002
24	Hepatitis B 01/2022 - 02/2002
23	Inflammation (Inflammations) 11/2021 - 05/2002
23	Sclerosing Cholangitis 01/2021 - 06/2003
21	Virus Diseases (Viral Diseases) 01/2019 - 02/2002
18	End Stage Liver Disease 12/2020 - 02/2003
17	Hepatitis D 01/2022 - 01/2002
15	Liver Failure 01/2021 - 02/2002
15	Chronic Hepatitis B 01/2020 - 01/2002
14	Ascites 01/2022 - 04/2003
13	Cholangiocarcinoma 01/2020 - 02/2002
12	Disease Progression 01/2021 - 02/2002
12	Acute Liver Failure (Fulminant Hepatic Failure) 08/2020 - 10/2006
12	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 02/2004
11	Pathologic Constriction (Stenosis) 01/2020 - 10/2006
9	Hemorrhage 01/2021 - 04/2003
9	Liver Neoplasms (Liver Cancer) 01/2021 - 04/2014
9	Neoplasm Metastasis (Metastasis) 11/2019 - 02/2002
9	Reinfection 01/2016 - 02/2003
8	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2020 - 05/2002
7	Portal Hypertension 01/2022 - 07/2003
7	Non-alcoholic Fatty Liver Disease 01/2021 - 02/2012
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2002
7	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021 - 01/2002
7	Insulin Resistance 01/2020 - 08/2004
7	Necrosis 11/2013 - 02/2007
6	Cholestasis 01/2019 - 05/2005
6	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017 - 06/2003
6	Coinfection 05/2012 - 03/2007
6	Viremia 02/2012 - 07/2004
6	Gilbert Disease 07/2009 - 05/2005
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 05/2012
5	Cholangitis 12/2021 - 05/2005
5	Persistent Infection 01/2017 - 02/2006

Drug/Important Bio-Agent (IBA)

57	Antiviral Agents (Antivirals)IBA 02/2022 - 02/2002
50	InterferonsIBA 01/2022 - 01/2002
44	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 02/2002
33	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2002
29	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
28	AntigensIBA 01/2022 - 07/2004
27	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2003
25	Interferon-alpha (Interferon Alfa)IBA 01/2022 - 01/2002
21	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2002
20	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 03/2007
19	BilirubinIBA 12/2021 - 02/2002
19	Pharmaceutical PreparationsIBA 03/2021 - 02/2002
18	AutoantibodiesIBA 01/2022 - 01/2002
17	AntibodiesIBA 01/2022 - 01/2002
16	CytokinesIBA 10/2020 - 10/2002
14	Peptides (Polypeptides)IBA 07/2021 - 09/2007
13	Messenger RNA (mRNA)IBA 01/2021 - 02/2002
12	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2012 - 08/2004
11	AlbuminsIBA 12/2021 - 01/2007
11	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 11/2006
10	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 10/2006
10	AutoantigensIBA 12/2019 - 11/2002
9	Hepatitis B e AntigensIBA 01/2020 - 01/2002
9	SofosbuvirIBA 01/2020 - 05/2013
9	EnzymesIBA 01/2019 - 08/2002
9	VaccinesIBA 01/2017 - 01/2003
9	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2014 - 02/2009
8	Budesonide (Pulmicort)FDA LinkGeneric 12/2021 - 10/2005
8	Azathioprine (Imuran)FDA LinkGeneric 12/2020 - 10/2010
8	Alanine Transaminase (SGPT)IBA 02/2020 - 01/2002
8	LigandsIBA 01/2019 - 11/2007
8	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2009
7	Immunoglobulin G (IgG)IBA 04/2022 - 01/2006
7	Transaminases (Aminotransferases)IBA 04/2022 - 02/2002
7	SteroidsIBA 12/2021 - 02/2004
7	Interleukin-6 (Interleukin 6)IBA 04/2018 - 07/2003
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 01/2006
7	Lamivudine (Epivir)FDA Link 05/2012 - 02/2002
7	hepatitis B hyperimmune globulinIBA 03/2011 - 02/2002
6	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 07/2005
6	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 07/2004
6	Bile Acids and Salts (Bile Acids)IBA 12/2019 - 12/2003
6	peginterferon alfa-2b (Pegintron)FDA Link 05/2014 - 09/2003
5	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 02/2011
5	peginterferon alfa-2a (Pegasys)FDA Link 01/2020 - 04/2010
5	Irinotecan (Camptosar)FDA LinkGeneric 11/2019 - 05/2005
5	AcidsIBA 10/2019 - 08/2007
5	Insulin (Novolin)FDA Link 01/2019 - 04/2003
5	Sorafenib (BAY 43-9006)FDA Link 03/2018 - 04/2013

Therapy/Procedure

151	Therapeutics 12/2021 - 01/2002
97	Liver Transplantation 01/2022 - 02/2002
27	Transplantation 01/2021 - 02/2003
15	Immunotherapy 01/2019 - 07/2004
12	Drug Therapy (Chemotherapy) 01/2019 - 11/2005
6	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022 - 05/2017
6	Drug Tapering 06/2015 - 05/2006
5	Organ Transplantation 09/2020 - 06/2003